K M Sarada Devi is an assistant professor in the department of biochemistry at Bharathiar University, Coimbatore, and Gurusaravanan is an assistant professor in the department of botany. Both of them have been granted patents by the Central Government.
Coimbatore: K M Sarada Devi is an assistant professor in the department of biochemistry at Bharathiar University, Coimbatore, and Gurusaravanan is an assistant professor in the department of botany.
Both of them have been granted patents by the Central Government for making silver nanoparticles from the tuber extracts of Senkanthal plant, the state flower of Tamil Nadu.
According to a press release issued by Bharathiar University: Many other types of metal nanoparticles produced by nanotechnology play an important role in the treatment of cancer.
In this situation, professors Saradadevi and Gurusaravanan of Bharathiar University carried out the research to detect silver nanoparticles using the sap of the Senkanthal plant tuber in a natural way.
At this stage, they discovered silver nanoparticles of uniform size and shape. In 2020, an application was made to the Indian Patent Office, Government of India.
Subsequently, the invention was granted patents on The 31st of last month. Following this, the vice-chancellor's committee member Lovlina Little Pilover and registrar Murugavel felicitated the professors. In the last 6 years, 32 patents have been registered with the efforts of the Intellectual Property Rights Centre of the University. This is what it says.
Professors Sarada Devi and Guru Saravanan said: Current cancer drugs destroy not only cancer-infected cells but also non-cancerous cells. This also affects the good cells. But silver nanoparticles have been discovered from the tuber extracts of the Senkanthal plant. These nanoparticles are easily absorbed by cancer-infected cells.
This makes it easier for the white cells in the blood to detect and destroy cancer-infected cells. These particles help in curing the cancer. Moreover, non-cancerous cells are protected from being destroyed. We started researching in 2015. Although it was discovered in 2018, we collected all the information and applied for a patent only in 2020.
In the first phase, we have successfully injected these nanoparticles into the rat. It will take a few years to bring these nanoparticles for human use. We are happy to have got the patent. This is what they said.
Both of them have been granted patents by the Central Government for making silver nanoparticles from the tuber extracts of Senkanthal plant, the state flower of Tamil Nadu.
According to a press release issued by Bharathiar University: Many other types of metal nanoparticles produced by nanotechnology play an important role in the treatment of cancer.
In this situation, professors Saradadevi and Gurusaravanan of Bharathiar University carried out the research to detect silver nanoparticles using the sap of the Senkanthal plant tuber in a natural way.
At this stage, they discovered silver nanoparticles of uniform size and shape. In 2020, an application was made to the Indian Patent Office, Government of India.
Subsequently, the invention was granted patents on The 31st of last month. Following this, the vice-chancellor's committee member Lovlina Little Pilover and registrar Murugavel felicitated the professors. In the last 6 years, 32 patents have been registered with the efforts of the Intellectual Property Rights Centre of the University. This is what it says.
Professors Sarada Devi and Guru Saravanan said: Current cancer drugs destroy not only cancer-infected cells but also non-cancerous cells. This also affects the good cells. But silver nanoparticles have been discovered from the tuber extracts of the Senkanthal plant. These nanoparticles are easily absorbed by cancer-infected cells.
This makes it easier for the white cells in the blood to detect and destroy cancer-infected cells. These particles help in curing the cancer. Moreover, non-cancerous cells are protected from being destroyed. We started researching in 2015. Although it was discovered in 2018, we collected all the information and applied for a patent only in 2020.
In the first phase, we have successfully injected these nanoparticles into the rat. It will take a few years to bring these nanoparticles for human use. We are happy to have got the patent. This is what they said.